CUFENCE 200 MG Israel - inglês - Ministry of Health

cufence 200 mg

mbi pharma ltd., israel - trientine as dihydrochloride - hard capsule - trientine as dihydrochloride 200 mg - trientine - cufence is indicated for the treatment of wilson’s disease in patients intolerant to d-penicillamine therapy, in adults, adolescents and children aged 5 years or older.

Trientine 167 mg hard capsules Irlanda - inglês - HPRA (Health Products Regulatory Authority)

trientine 167 mg hard capsules

tillomed pharma gmbh - trientine dihydrochloride - capsule, hard - trientine

TRIENTINE RAZ 250 MG Israel - inglês - Ministry of Health

trientine raz 250 mg

raz pharmaceutics ltd, israel - trientine dihydrochloride - capsules - trientine dihydrochloride 250 mg - trientine - for the treatment of wilson’s disease in patient's intolerant of d-penicillaminetherapy, in adults, adolescents and children aged 5 years or older.

Trientine 200mg capsules Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

trientine 200mg capsules

univar solutions b.v. - trientine dihydrochloride - oral capsule - 200mg

MAR-TRIENTINE CAPSULE Canadá - inglês - Health Canada

mar-trientine capsule

marcan pharmaceuticals inc - trientine hydrochloride - capsule - 250mg - trientine hydrochloride 250mg - heavy metal antagonists

TRIENTINE HCL MEDOMIE 250 MG CAPSULES Israel - inglês - Ministry of Health

trientine hcl medomie 250 mg capsules

medomie pharma ltd, israel - trientine hydrochloride - hard capsule - trientine hydrochloride 250 mg - trientine - trientine medomie is indicated for the treatment of wilson’s disease in patients intolerant to d-penicillamine therapy, in adults, adolescents and children aged 5 years or older.